Clinical Trials Browser

Unknown × Breast Neoplasms × Goserelin × Clear all

NCT05800197 2023-04-06

NEMO

Breast Neoplasms

NCT02914158 2023-01-17

ASPAIT

Phase 3 Unknown

Breast Neoplasms

NCT05253066 2022-02-23

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

Phase 2/3 Unknown

Breast Neoplasms

NCT02626507 2022-02-09

Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer

Phase 1 Unknown

Breast Neoplasms

NCT03591549 2018-07-23

Fulvestrant in Metastatic Breast Cancer

Phase 4 Unknown

Breast Neoplasms

NCT03373708 2017-12-18

Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

Phase 2/3 Unknown

Breast Diseases, Breast Neoplasms

NCT01266213 2017-05-01

FLAG

Phase 2 Unknown

Breast Neoplasms

NCT02132390 2014-06-04

Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea

Phase 3 Unknown

Breast Neoplasms

NCT02072512 2014-02-26

PROOF

Phase 2 Unknown

Breast Neoplasms

NCT00002460 2013-08-07

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Phase 2 Unknown

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00912548 2009-06-16

ASTRRA

Phase 3 Unknown

Breast Neoplasms

NCT00488722 2007-06-26

A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer

Phase NA Unknown

Breast Neoplasms